Yangkai Xu

Yangkai Xu

Auto-generated profile, based on publicly available information

Yangkai Xu

Peking University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2022
Verified
Book Chapter
Closed access
PDF file
SDSiying Deng
Siying Deng
YXYangkai Xu
Yangkai Xu
Lemin ZhengLemin Zheng
Lemin Zheng

17 May 2022
Verified
Book Chapter
Closed access
PDF file
YWYufei Wu
Yufei Wu
YXYangkai Xu
Yangkai Xu
JCJie Chen
Jie Chen
ZMZhao Mingming
Zhao Mingming
KRKerry-Anne Rye
Kerry-Anne Rye

19 September 2022 in Global Translational Medicine
Verified
Journal Article
Open access
PDF file
WSWenxin Shan
Wenxin Shan
HCHongtu Cui
Hongtu Cui
YXYangkai Xu
Yangkai Xu
JXJing Xue
Jing Xue
Lemin ZhengLemin Zheng
Lemin Zheng
Cardiovascular disease (CVD) refers to a class of diseases related to the heart or blood vessels that have high global incidence. Succinate is generally considered an important intermediate product of the tricarboxylic acid cycle. Recent studies have shown that succinate is related to the pathophysiology of CVD, such as atherosclerosis, acute aortic dissection, hypertension, myocardial ischemia-reperfusion injury, and heart failure. It may represent a potential target or biomarker for CVD. It has been demonstrated that succinate not only participates in various energy metabolic pathways but also plays an important role in various pathophysiological activities as a signaling molecule. Given the significance of metabolism in CVD, it is important to focus on the metabolic regulation mechanism of succinate in CVD. This review outlines the latest evidence pointing to the potential role of succinate in CVD, along with its mechanisms, and updates the current understanding on the role of succinate in CVD. Further studies may focus on identifying succinate, its receptor, and its downstream signaling molecules as new targets for the prevention and treatment of CVD.